Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Molecular Immunology
|
October 31, 2001
Presentation of antigens by MHC class II molecules: getting the most out of them
J A Villadangos
Immunity
|
February 7, 2001
Proteolysis in MHC class II antigen presentation: who's in charge?
J A Villadangos, H L Ploegh
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1994
Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity
J A Villadangos, B Galocha, J A López de Castro
The Journal of Experimental Medicine
|
March 1, 1993
Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B
S Rojo, F García, J A Villadangos, et al.
Mucosal Immunology
|
January 15, 2015
Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection
L M Wakim, J Smith, I Caminschi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1993
Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2
D López, D F Barber, J A Villadangos, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1992
Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition
J A Villadangos, B Galocha, D López, et al.
The EMBO Journal
|
March 4, 2000
Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM
J A Villadangos, C Driessen, G P Shi, et al.
The Journal of Experimental Medicine
|
August 18, 1997
Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism
J A Villadangos, R J Riese, C Peters, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 1998
Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
J Deussing, W Roth, P Saftig, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Molecular Immunology
|
October 31, 2001
Presentation of antigens by MHC class II molecules: getting the most out of them
J A Villadangos
Immunity
|
February 7, 2001
Proteolysis in MHC class II antigen presentation: who's in charge?
J A Villadangos, H L Ploegh
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1994
Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity
J A Villadangos, B Galocha, J A López de Castro
The Journal of Experimental Medicine
|
March 1, 1993
Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B
S Rojo, F García, J A Villadangos, et al.
Mucosal Immunology
|
January 15, 2015
Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection
L M Wakim, J Smith, I Caminschi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1993
Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2
D López, D F Barber, J A Villadangos, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1992
Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition
J A Villadangos, B Galocha, D López, et al.
The EMBO Journal
|
March 4, 2000
Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM
J A Villadangos, C Driessen, G P Shi, et al.
The Journal of Experimental Medicine
|
August 18, 1997
Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism
J A Villadangos, R J Riese, C Peters, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 1998
Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
J Deussing, W Roth, P Saftig, et al.
Page
of 3